Think Tank

Latest California Healthline Stories

What To Do About High-Priced Drugs?

According to a new analysis, California taxpayers could pay as much as $5.1 billion a year to treat hepatitis C patients in state-funded programs, adding fuel to some experts’ contention that expensive drugs may bankrupt the health system. We asked consumer advocates, insurers, state health officials and pharmaceutical manufacturers to weigh in on the issue.

How To Pay for Retiree Health Coverage

We asked politicians, academics and consumer advocates how California should pay for the rising costs of providing health coverage for retired state workers.

New Tools To Stem Rising Prices

We asked stakeholders, researchers and consumer advocates to weigh in on new anti-inflationary tools such as payment limits for specific medical treatments and new rules for containing prescription drug spending.